Cargando…
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
SIMPLE SUMMARY: Cancer outcomes are often indexed to the quality of the immune response to the tumor. Among immune cells, Foxp3(+) regulatory T cells (Treg cells) are potent inhibitors of cancer immunity, and their presence within solid tumors is generally associated with a poor prognosis. Thus, und...
Autores principales: | Stéphan, Pierre, Lautraite, Raphaëlle, Voisin, Allison, Grinberg-Bleyer, Yenkel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693300/ https://www.ncbi.nlm.nih.gov/pubmed/33143070 http://dx.doi.org/10.3390/cancers12113194 |
Ejemplares similares
-
A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis
por: Lalle, Guilhem, et al.
Publicado: (2021) -
NF-κB in Cancer Immunity: Friend or Foe?
por: Lalle, Guilhem, et al.
Publicado: (2021) -
In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice
por: Martin, Gaëlle H., et al.
Publicado: (2013) -
Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κB
por: Lubrano di Ricco, Martina, et al.
Publicado: (2020) -
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
por: Grinberg-Bleyer, Yenkel, et al.
Publicado: (2010)